0001567619-19-023733.txt : 20191230 0001567619-19-023733.hdr.sgml : 20191230 20191230192720 ACCESSION NUMBER: 0001567619-19-023733 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191203 FILED AS OF DATE: 20191230 DATE AS OF CHANGE: 20191230 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIENAIME JEAN JACQUES CENTRAL INDEX KEY: 0001221590 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 191317717 MAIL ADDRESS: STREET 1: 925 PAGE MILL ROAD CITY: PALO ALTO STATE: CA ZIP: 94304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc1.xml FORM 4 X0306 4 2019-12-03 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001221590 BIENAIME JEAN JACQUES C/O BIOMARIN PHARMACEUTICAL INC. 770 LINDARO ST. SAN RAFAEL CA 94901 1 1 0 0 Chief Executive Officer Common Stock 2019-12-26 4 M 0 3000 21.51 A 330530 D Common Stock 2019-12-26 4 S 0 3000 86.43 D 327530 D Common Stock 2019-12-27 4 M 0 5000 21.51 A 332530 D Common Stock 2019-12-27 4 S 0 5000 86.16 D 327530 D Common Stock 2019-12-03 5 G 0 630 0 D 180261 I Shares held by Jean-Jacques Bienaime Family Trust Stock Option (Right to buy Common Stock) 21.51 2019-12-26 4 M 0 3000 0 D 2010-11-12 2020-05-11 Common Stock 3000 120000 D Stock Option (Right to buy Common Stock) 21.51 2019-12-27 4 M 0 5000 0 D 2010-11-12 2020-05-11 Common Stock 5000 115000 D Trade made pursuant to a 10b5-1 plan executed on June 11, 2019. On November 26, 2019, the reporting person filed a Form 4 which inadvertently reported a gift of 450 shares made from the reporting person and not from the reporting person's trust. This Form 4 corrects such error by increasing the total amount of securities beneficially owned by the reporting person by such 450 shares. The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 10 shares, with the reporting person's purchase of shares at a price of $75.3786 on November 11, 2019. The reporting person has paid to the Issuer the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs. Trade made pursuant to a 10b5-1 plan executed on September 6, 2019. On December 3, 2019 the reporting person gifted 630 shares to a charitable organization. On November 26, 2019, the reporting person filed a Form 4 which inadvertently reported a gift of 450 shares made from the reporting person and not from the reporting person's trust. This Form 4 corrects such error by decreasing the total amount of securities beneficially owned by the reporting person's trust by such 450 shares. Reflects the number of options outstanding after the transactions from this specific stock option grant. /s/ Eric Fleekop, Attorney-in-Fact 2019-12-30